Skip to content
Reflections of yellow marbles on metal holders
Reflections of yellow marbles on metal holders

Life Sciences

Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.

The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.

We have won a reputation for providing far-sighted advice to some of the world’s leading life science companies.

News and insights

Publications: 20 March 2023

Abuse of dominance enforcement paves path for digital reform

2022 saw a significant decrease in fines across the world for abuse of dominance cases. Authorities continued to focus on ‘Big Tech’, but were more willing to accept commitments from firms in place of…

Read more
test tubes and dropper

Blog Post: 08 March 2023

Podcast: Surviving the "valley of death" - How early-stage life sciences companies can overcome funding gaps and IP hurdles

Tine Carmeliet, Juno Hautekiet and Geert Glas discuss how early-stage life sciences companies can survive the so-called “valley of death”. This is the funding gap between making a promising scientific…

Read more
Close up image of a circuit board with light trials

Publications: 23 February 2023

Scrutiny of tech deals remains a priority with PE and labour markets in the spotlight

Digital/tech transactions remain high on the enforcement agenda. Last year brought high-profile tech cases and progression of new digital rules. Overall, however, antitrust intervention focused on…

Read more
Colourful office building windows

Publications: 16 February 2023

Sanctions in the spotlight: the High Court considers Russia sanctions implications

The High Court in London has issued a number of judgments in recent weeks that consider the implications of the sanctions that have been imposed on Russia in the last 12 months. In this article, we…

Read more

Recognition

Related links

Life Sciences Hub

We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector.

Read more

CRISPR microsite

The characterisation and optimisation of the CRISPR (also known as CRISPR-Cas) system for gene editing and other applications, is undoubtedly one of the most powerful and ground breaking advances in the history of biotechnology.

Go to microsite

Growth Capital microsite

Allen & Overy is an engaged and active player in the growth company ecosystem.

Go to microsite

UPC microsite

Ready for take-off

Go to microsite

Related content

Global trends in merger control enforcement

Record levels in the first half of 2018 and considerable contraction in the second.